Abstract Background and Aim Aberrant DNA methylation has been found in various cancer
types including gastric cancer, yet the genome‐wide DNA methylation profile of gastric …

Background Aberrant DNA methylation is involved in gastric carcinogenesis and may serve
as a useful biomarker in the diagnosis and detection of gastric cancer (GC) recurrence …

Background Measuring the DNA methylome may offer the opportunity to identify novel
disease biomarkers and insights into disease mechanisms. Although aberrant DNA …

Abnormal DNA methylation is an epigenetic mechanism that promotes gastric
carcinogenesis. While the abnormal methylation at promoter regions has been …

Background Epigenetic alteration of gene expression is a common event in human cancer.
DNA methylation is a well-known epigenetic process, but verifying the exact nature of …

Abnormal DNA methylation, an epigenetic modification, has increasingly been linked to the
pathogenesis of many human cancers. However, there has been little focus on the DNA …

Research on the DNA methylation status of gastric cancer (GC) has primarily focused on
identifying invasive GC to develop biomarkers for diagnostic. However, DNA methylation in …

Background Although primary (PGC) and remnant gastric cancers (RGC) both originate from
the same gastrointestinal organ, they have very distinct clinicopathological behaviors. We …

DNA methylation is a regulatory mechanism in epigenetics that is frequently altered during
human carcinogenesis. To detect critical methylation events associated with gastric cancer …

Although gastric cancer (GC) in young adults (≤ 45 years) accounts for fewer than 10% of
newly diagnosed cases, the young patients are more likely to have advanced disease at …